Regeneron is buying bankrupt genetic testing firm 23andMe, which helped usher in the era of consumer DNA test kits nearly two ...

The backup bidder to Regeneron is a nonprofit apparently started by former 23andMe CEO Anne Wojcicki. Meet the company that ...

How exactly 23andMe will shake out after the Regeneron purchase is to be seen. The company has taken a dramatic fall in ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Me, which helped popularize ancestry tracing through genetic testing, filed for bankruptcy protection and will seek a sale.

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

Biotechnology leader Regeneron Pharmaceuticals is acquiring genetic testing firm 23andMe for $256 million following its ...

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

The company has signed up to pay $256 million for 23andMe and nearly all of its assets, including its R&D services operations ...